151 related articles for article (PubMed ID: 10771693)
1. [Anti-angiogenic reagents].
Shibuya M
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1182-7. PubMed ID: 10771693
[No Abstract] [Full Text] [Related]
2. [VEGF].
Yoshiji H; Fukui H; Kuriyama S
Nihon Rinsho; 2001 Oct; 59 Suppl 6():189-94. PubMed ID: 11761939
[No Abstract] [Full Text] [Related]
3. Regulation of angiogenesis via vascular endothelial growth factor receptors.
Veikkola T; Karkkainen M; Claesson-Welsh L; Alitalo K
Cancer Res; 2000 Jan; 60(2):203-12. PubMed ID: 10667560
[No Abstract] [Full Text] [Related]
4. Vascular endothelial growth factor (VEGF) receptor-2 antagonists inhibit VEGF- and basic fibroblast growth factor-induced angiogenesis in vivo and in vitro.
Tille JC; Wood J; Mandriota SJ; Schnell C; Ferrari S; Mestan J; Zhu Z; Witte L; Pepper MS
J Pharmacol Exp Ther; 2001 Dec; 299(3):1073-85. PubMed ID: 11714897
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenesis and tumor growth. Angiogenic factors and tumor growth].
Plouet J
Ann Pathol; 1999; 19(5 Suppl):S70-1. PubMed ID: 10599456
[No Abstract] [Full Text] [Related]
6. [Eye and pathologic angiogenesis].
Ishibashi T
Fukuoka Igaku Zasshi; 2000 Nov; 91(11):277-83. PubMed ID: 11187718
[No Abstract] [Full Text] [Related]
7. [Growth factors binding heparin: FGF and VEGF. Physiological and physiopathological importance, therapeutic implications in diabetic retinopathy].
Favard C; Patry V; Prats H; Plouet J; Bayard F
Journ Annu Diabetol Hotel Dieu; 1995; ():39-51. PubMed ID: 7602891
[No Abstract] [Full Text] [Related]
8. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor.
Smith LE; Shen W; Perruzzi C; Soker S; Kinose F; Xu X; Robinson G; Driver S; Bischoff J; Zhang B; Schaeffer JM; Senger DR
Nat Med; 1999 Dec; 5(12):1390-5. PubMed ID: 10581081
[TBL] [Abstract][Full Text] [Related]
9. Receptor tyrosine kinase signaling in vascular development.
Merenmies J; Parada LF; Henkemeyer M
Cell Growth Differ; 1997 Jan; 8(1):3-10. PubMed ID: 8993829
[No Abstract] [Full Text] [Related]
10. Vascular endothelial growth factor: environmental controls and effects in angiogenesis.
Hlatky L; Hahnfeldt P; Tsionou C; Coleman CN
Br J Cancer Suppl; 1996 Jul; 27():S151-6. PubMed ID: 8763869
[No Abstract] [Full Text] [Related]
11. VEGF receptor signal transduction.
Matsumoto T; Claesson-Welsh L
Sci STKE; 2001 Dec; 2001(112):re21. PubMed ID: 11741095
[TBL] [Abstract][Full Text] [Related]
12. VEGFs, receptors and angiogenesis.
Veikkola T; Alitalo K
Semin Cancer Biol; 1999 Jun; 9(3):211-20. PubMed ID: 10343072
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor: acting as an autocrine growth factor for human gastric adenocarcinoma cell MGC803.
Tian X; Song S; Wu J; Meng L; Dong Z; Shou C
Biochem Biophys Res Commun; 2001 Aug; 286(3):505-12. PubMed ID: 11511087
[TBL] [Abstract][Full Text] [Related]
14. Vascular endothelial growth factor (VEGF) and its effect on angiogenesis.
Jośko J; Gwóźdź B; Jedrzejowska-Szypułka H; Hendryk S
Med Sci Monit; 2000; 6(5):1047-52. PubMed ID: 11208453
[TBL] [Abstract][Full Text] [Related]
15. Selective inhibition of vascular endothelial growth factor (VEGF) receptor 2 (KDR/Flk-1) activity by a monoclonal anti-VEGF antibody blocks tumor growth in mice.
Brekken RA; Overholser JP; Stastny VA; Waltenberger J; Minna JD; Thorpe PE
Cancer Res; 2000 Sep; 60(18):5117-24. PubMed ID: 11016638
[TBL] [Abstract][Full Text] [Related]
16. Lymphatic versus blood vascular endothelial growth factors and receptors in humans.
Partanen TA; Paavonen K
Microsc Res Tech; 2001 Oct; 55(2):108-21. PubMed ID: 11596156
[TBL] [Abstract][Full Text] [Related]
17. Targeting vascular endothelial growth factor (VEGF) for anti-tumor therapy, by anti-VEGF neutralizing monoclonal antibodies or by VEGF receptor tyrosine-kinase inhibitors.
Schlaeppi JM; Wood JM
Cancer Metastasis Rev; 1999; 18(4):473-81. PubMed ID: 10855790
[TBL] [Abstract][Full Text] [Related]
18. [Role of vascular endothelial growth factor in microvascular abnormalities in diabetic retinopathy].
Takagi H
Nihon Ronen Igakkai Zasshi; 2000 Aug; 37(8):603-6. PubMed ID: 11086383
[No Abstract] [Full Text] [Related]
19. [The biology of lymphatic vessels - new findings ].
Jussila L; Alitalo K; Kaipainen A
Duodecim; 1998; 114(4):343-8. PubMed ID: 11466946
[No Abstract] [Full Text] [Related]
20. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies.
Aiello LP
Invest Ophthalmol Vis Sci; 1997 Aug; 38(9):1647-52. PubMed ID: 9286253
[No Abstract] [Full Text] [Related]
[Next] [New Search]
